NCT02828111View on ClinicalTrials.gov

Clinical Trial of Patidegib Gel 2%, 4%, and Vehicle Applied Once or Twice Daily to Decrease the GLI1 Biomarker in Sporadic Nodular Basal Cell Carcinomas

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 11, 2016

Primary Completion Date

November 9, 2017

Study Completion Date

November 9, 2017

Conditions
Basal Cell Carcinomas
Interventions
DRUG

Patidegib

DRUG

Vehicle gel

Trial Locations (1)

90094

12121 Bluff Creek Drive Suite 100, Los Angeles

Sponsors

Lead Sponsor

PellePharm, Inc.
All Listed Sponsors
lead

PellePharm, Inc.

INDUSTRY